The global market for Cardiac Defibrillators was valued at US$14.5 Billion in 2024 and is projected to reach US$22.9 Billion by 2030, growing at a CAGR of 7.9% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Cardiac Defibrillators market.
The growing geriatric population, which is more susceptible to CVDs, requires advanced healthcare solutions, further fueling the demand for defibrillators. In addition, awareness and training programs that promote the use of defibrillators, especially automated external defibrillators (AEDs), increase accessibility to these life-saving devices in public spaces. Government initiatives and funding support their adoption across healthcare facilities, while rising investments in healthcare infrastructure and growing awareness in emerging markets such as Asia-Pacific and Latin America spur growth.
The integration of Artificial Intelligence (AI) and the Internet of Things (IoT) into defibrillators enables predictive maintenance, real-time monitoring, and connectivity. Artificial Intelligence (AI) significantly impacts how defibrillators work, making them more efficient through machine learning algorithms that enhance life-saving treatments.
Wearable defibrillators have become popular as non-invasive, temporary solutions for patients awaiting implantable devices. Subcutaneous implantable defibrillators (S-ICD) are gaining traction because of their less invasive nature, which reduces infection risk. Additionally, smart monitoring enables continuous, real-time patient monitoring and data sharing with healthcare providers.
Segments: Product Segment (Implantable / Internal Cardiac Defibrillator, External Cardiac Defibrillator); End-Use (Hospitals, Public Access, Other End-Uses).
Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.
Global Cardiac Defibrillators Market - Key Trends and Drivers Summarized
Cardiac defibrillators are essential medical devices used to treat cardiac arrhythmias, especially ventricular fibrillation and ventricular tachycardia. Several significant factors drive the growth of the cardiac defibrillator market. The increasing prevalence of cardiovascular diseases (CVDs), such as heart attacks and strokes, significantly boosts demand for defibrillators. The World Health Organization identifies CVDs as the leading cause of death worldwide. Technological advancements also play a critical role, with innovations like wireless connectivity, remote monitoring, and more compact designs making defibrillators increasingly effective and user-friendly. The latest implantable devices offer better longevity and improved data reporting.The growing geriatric population, which is more susceptible to CVDs, requires advanced healthcare solutions, further fueling the demand for defibrillators. In addition, awareness and training programs that promote the use of defibrillators, especially automated external defibrillators (AEDs), increase accessibility to these life-saving devices in public spaces. Government initiatives and funding support their adoption across healthcare facilities, while rising investments in healthcare infrastructure and growing awareness in emerging markets such as Asia-Pacific and Latin America spur growth.
The integration of Artificial Intelligence (AI) and the Internet of Things (IoT) into defibrillators enables predictive maintenance, real-time monitoring, and connectivity. Artificial Intelligence (AI) significantly impacts how defibrillators work, making them more efficient through machine learning algorithms that enhance life-saving treatments.
Wearable defibrillators have become popular as non-invasive, temporary solutions for patients awaiting implantable devices. Subcutaneous implantable defibrillators (S-ICD) are gaining traction because of their less invasive nature, which reduces infection risk. Additionally, smart monitoring enables continuous, real-time patient monitoring and data sharing with healthcare providers.
Report Scope
The report analyzes the Cardiac Defibrillators market, presented in terms of units. The analysis covers the key segments and geographic regions outlined below.Segments: Product Segment (Implantable / Internal Cardiac Defibrillator, External Cardiac Defibrillator); End-Use (Hospitals, Public Access, Other End-Uses).
Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Implantable / Internal Cardiac Defibrillator segment, which is expected to reach US$12.3 Billion by 2030 with a CAGR of a 6.0%. The External Cardiac Defibrillator segment is also set to grow at 10.4% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $3.9 Billion in 2024, and China, forecasted to grow at an impressive 7.5% CAGR to reach $3.6 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Cardiac Defibrillators Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Cardiac Defibrillators Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Cardiac Defibrillators Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as Abbott Laboratories, Biotronik GmbH & Co. KG, Boston Scientific Corporation, Cardiac Science Corporation, GE Healthcare Ltd. and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the 48 companies featured in this Cardiac Defibrillators market report include:
- Abbott Laboratories
- Biotronik GmbH & Co. KG
- Boston Scientific Corporation
- Cardiac Science Corporation
- GE Healthcare Ltd.
- Medtronic, Inc.
- Philips Healthcare
- Physio-Control Inc.
- St. Jude Medical Inc.
- Zoll Medical Corporation
Tariff Impact Analysis: Key Insights for 2025
Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.
What’s Included in This Edition:
- Tariff-adjusted market forecasts by region and segment
- Analysis of cost and supply chain implications by sourcing and trade exposure
- Strategic insights into geographic shifts
Buyers receive a free July 2025 update with:
- Finalized tariff impacts and new trade agreement effects
- Updated projections reflecting global sourcing and cost shifts
- Expanded country-specific coverage across the industry
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
REST OF EUROPE
ASIA-PACIFIC
REST OF WORLD
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Biotronik GmbH & Co. KG
- Boston Scientific Corporation
- Cardiac Science Corporation
- GE Healthcare Ltd.
- Medtronic, Inc.
- Philips Healthcare
- Physio-Control Inc.
- St. Jude Medical Inc.
- Zoll Medical Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 276 |
| Published | April 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 14.5 Billion |
| Forecasted Market Value ( USD | $ 22.9 Billion |
| Compound Annual Growth Rate | 7.9% |
| Regions Covered | Global |
